EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Feeder-free generation of functional dendritic cells from human pluripotent stem cells

Wei-Hung Jung, Andrew Khalil, Yoav Binenbaum, Joshua M Price, Kyle H Vining, Tenzin Lungjangwa, Miguel C Sobral, Rudolf Jaenisch, David J Mooney

Journal for ImmunoTherapy of Cancer · 2026-05 · 14 (5) · e014402

DOI: 10.1136/jitc-2025-014402 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal for ImmunoTherapy of Cancer, online erschienen am 13.05.2026. Verfasst von Wei-Hung Jung und 8 weiteren Autor:innen. Beteiligte Einrichtung: John A Paulson School of Engineering and Applied Sciences, Harvard University, Cambridge, Massachusetts, USA. Hauptthemen laut MEDLINE: Dendritic Cells, Pluripotent Stem Cells, Cell Culture Techniques. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Wellcome Leap HOPE program, National Institute of Dental and Craniofacial Research, National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The scarcity of primary conventional dendritic cells (cDCs) and the limited functionality of monocyte-derived dendritic cells (moDCs) have long hindered mechanistic and translational studies in human dendritic cell (DC) biology and immunotherapy.

Methods

We developed a feeder-free differentiation platform to generate CD1c + CD141 + human pluripotent stem cell-derived conventional dendritic cells (hPSC-cDCs) to provide a scalable source of DCs with defined properties. A Design-of-Experiments (DoE) optimization strategy was applied to refine cytokine and serum conditions, with the goal of enhancing differentiation efficiency while reducing cytokine demand. The resulting hPSC-cDCs were phenotypically, transcriptionally, and functionally characterized in comparison with primary cDC subsets and moDCs. Functional assays assessed antigen uptake, cytokine production, and the ability to prime antigen-specific CD8 + T cells.

Results

The optimized protocol increased hPSC-cDC yield by more than twofold while reducing cytokine usage. hPSC-cDCs expressed canonical cDC2 markers and aligned transcriptionally with primary cDC2s. These cells exhibited efficient phagocytic activity, robust cytokine secretion in response to poly(I:C) or combined Toll-like receptors agonists, and a partially activated basal state resembling primary CD1c + CD141 + DCs in human tissues. Functionally, hPSC-cDCs induced stronger antigen-specific CD8 + T-cell proliferation, activation, and effector differentiation than moDCs.

Conclusions

This feeder-free and DoE-optimized system enables reproducible, large-scale generation of functional hPSC-cDCs that phenotypically and transcriptionally resemble primary cDC2s while exhibiting stronger T-cell priming capacity than moDCs. The platform provides a defined and scalable resource for mechanistic studies, vaccine development, and ex vivo T-cell expansion for cancer immunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dendritic CellsPluripotent Stem CellsCell Culture TechniquesHumansCell DifferentiationCytokinesCD8-Positive T-LymphocytesAntigens, CD1Cells, Cultured

Stichwörter der Autor:innen

Antigen presentationCD1c⁺CD141⁺ dendritic cellsConventional dendritic cellsDesign of experimentsHuman pluripotent stem cellsImmunotherapyIn vitro differentiationT cell priming

Substanzen

CytokinesAntigens, CD1

Autor:innen und Institutionen

  • John A Paulson School of Engineering and Applied Sciences, Harvard University, Cambridge, Massachusetts, USA.
  • Wyss Institute for Biologically Inspired Engineering, Harvard University, Cambridge, Massachusetts, USA.
  • Whitehead Institute for Biomedical Research, Cambridge, Massachusetts, USA.
  • Department of Biomedical Engineering, University of Minnesota, Minneapolis, Minnesota, USA.
  • Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts, USA.
  • Department of Preventative and Restorative Sciences, School of Dental Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

Förderung

  • Wellcome Leap HOPE program
  • National Institute of Dental and Craniofacial Research
  • National Cancer Institute
  • National Institute of Allergy and Infectious Diseases

Zitieren

APA

Jung, W. H., Khalil, A., Binenbaum, Y., Price, J. M., Vining, K. H., Lungjangwa, T., Sobral, M. C., Jaenisch, R., & Mooney, D. J. (2026). Feeder-free generation of functional dendritic cells from human pluripotent stem cells. Journal for ImmunoTherapy of Cancer, 14(5), e014402. https://doi.org/10.1136/jitc-2025-014402

Vancouver

Jung WH, Khalil A, Binenbaum Y, Price JM, Vining KH, Lungjangwa T, et al. Feeder-free generation of functional dendritic cells from human pluripotent stem cells. Journal for ImmunoTherapy of Cancer. 2026;14(5):e014402. doi:10.1136/jitc-2025-014402

BibTeX
@article{Jung2026,
  author = {Jung, Wei-Hung and Khalil, Andrew and Binenbaum, Yoav and Price, Joshua M and Vining, Kyle H and Lungjangwa, Tenzin and Sobral, Miguel C and Jaenisch, Rudolf and Mooney, David J},
  title = {Feeder-free generation of functional dendritic cells from human pluripotent stem cells},
  journal = {Journal for ImmunoTherapy of Cancer},
  year = {2026},
  volume = {14},
  number = {5},
  pages = {e014402},
  doi = {10.1136/jitc-2025-014402}
}
Kostenlos starten →